CLOPIDOGREL BISULFATE
Generic: CLOPIDOGREL BISULFATE
Rising Pharma HoldingsManufacturer
ORALRoute
CLOPIDOGREL BISULFATEActive Substance
2017-02-02Original Approval
CLOPIDOGREL BISULFATE is FDA application ANDA204359, sponsored by RISING. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2018-11-07
Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's LaboratoFailed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th
Class II2018-12-10
Clopidogrel Tablets, USP, 300 mg, 30 (5 x 6 unit-dose) count blister pack, Rx only, Manufactured by Dr. Reddy's LaboratoFailed dissolution specification -Two additional lots being recalled due to Out-of-Specification res
Top Reported Reactions
1
DYSPNOEA
918 reports
2
FATIGUE
830 reports
3
MYOCARDIAL INFARCTION
798 reports
4
DRUG INEFFECTIVE
737 reports
5
NAUSEA
681 reports
6
DIZZINESS
675 reports
7
DIARRHOEA
668 reports
8
ANAEMIA
651 reports
9
ASTHENIA
629 reports
10
OFF LABEL USE
610 reports